The company's total income has increased by 80.6% at Rs. 924.5 crore for the quarter against Rs. 511.9 crore in the corresponding quarter of the previous year.
The company had reported a net profit of Rs.70.7 crore for the corresponding quarter last year, it said in a filing to the BSE.
Net sales in third quarter stood at Rs.921 crore, up 80.2% from Rs.511 crore in the year-ago period.
The company's total income has increased by 80.6% at Rs. 924.5 crore for the quarter against Rs. 511.9 crore in the corresponding quarter of the previous year.
On a standalone basis,the company has posted a net profit of Rs. 280.1 crore for the quarter ended December 31, 2015 as compared to Rs. 73.9 crore for the quarter ended December 31, 2014. Total Income has increased from Rs. 502.1 crore for the quarter ended December 31, 2014 to Rs. 900.5 crore for the quarter ended December 31, 2015.
Stock Commentary:
Alembic Pharmaceuticals Ltd is currently trading at Rs. 619, up by Rs. 31.45 or 5.35% from its previous closing of Rs. 587.55 on the BSE.
The scrip opened at Rs. 604 and has touched a high and low of Rs. 630.7 and Rs. 601.05 respectively. So far 393030(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 11075.32 crore.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 791.7 on 15-Jul-2015 and a 52 week low of Rs. 381.9 on 26-Feb-2015. Last one week high and low of the scrip stood at Rs. 671 and Rs. 573.55 respectively.
The promoters holding in the company stood at 74.13 % while Institutions and Non-Institutions held 12.6 % and 13.28 % respectively.
The stock is currently trading above its 100 DMA.
No comments:
Post a Comment